TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN EVERYDAY PRACTICE: Identification of Health Care Constraints in Germany-The PONS Study.
作者： Christoph Ehlken , Thomas Wilke , Ulrike Bauer-Steinhusen , Hansjürgen T. Agostini , Zoran Hasanbasic
DOI: 10.1097/IAE.0000000000001681
关键词: Health care 、 Observational study 、 Internal medicine 、 Visual acuity 、 Age related 、 Vascular endothelial growth factor 、 Clinical Practice 、 Macular degeneration 、 Medicine 、 Pons 、 Physical therapy
摘要: Purpose:The PONS study was conceived to analyze the extent of nonpersistence (NP) and nonadherence (NA) in treatment patients with neovascular age-related macular degeneration everyday clinical practice Germany. Further objectives were identify factors that can affect NP NA t
sci-hub.se 参考文章(24)
F. Ziemssen, P. Wiedemann, A. Kampik, F. Holz, K.U. Bartz-Schmidt, Intravitreal injections of medications in Germany. Contract situation and legal conditions Ophthalmologe. ,vol. 106, pp. 465- ,(2009) , 10.1007/S00347-009-1964-7
F. Ziemssen, , N. Eter, S. Fauser, S. Bopp, M. Radermacher, Z. Hasanbasic, F.G. Holz, Retrospektive Untersuchung der Anti-VEGF-Behandlungsrealität und Wirksamkeit bei Patienten mit neovaskulärer altersabhängiger Makuladegeneration (nAMD) in Deutschland Ophthalmologe. ,vol. 112, pp. 246- 254 ,(2015) , 10.1007/S00347-014-3217-7
Robert Horne, Patients' beliefs about treatment: The hidden determinant of treatment outcome? Journal of Psychosomatic Research. ,vol. 47, pp. 491- 495 ,(1999) , 10.1016/S0022-3999(99)00058-6
Daniel F Martin, Maureen G Maguire, GSet al Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe, None, Ranibizumab and bevacizumab for neovascular age-related macular degeneration. The New England Journal of Medicine. ,vol. 364, pp. 1897- 1908 ,(2011) , 10.1056/NEJMOA1102673
F. Ziemssen, A. Kampik, P. Wiedemann, K.U. Bartz-Schmidt, F. Holz, Intravitreale operative Medikamentenapplikation in Deutschland Ophthalmologe. ,vol. 106, pp. 465- 470 ,(2009) , 10.1007/S00347-009-1964-7
Paula Anne Newman-Casey, Alan L. Robin, Taylor Blachley, Karen Farris, Michele Heisler, Ken Resnicow, Paul P. Lee, The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey Ophthalmology. ,vol. 122, pp. 1308- 1316 ,(2015) , 10.1016/J.OPHTHA.2015.03.026
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Quan Dong Nguyen, Allen C Ho, Yuichiro Ogura, Christian Simader, Glenn J Jaffe, Jason S Slakter, George D Yancopoulos, Neil Stahl, Robert Vitti, Alyson J Berliner, Yuhwen Soo, Majid Anderesi, Olaf Sowade, Oliver Zeitz, Christiane Norenberg, Rupert Sandbrink, Jeffrey S Heier, None, Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six–Week Results of the VIEW Studies Ophthalmology. ,vol. 121, pp. 193- 201 ,(2014) , 10.1016/J.OPHTHA.2013.08.011
Thomas Wilke, Sabrina Müller, Donald E. Morisky, Toward identifying the causes and combinations of causes increasing the risks of nonadherence to medical regimens: combined results of two German self-report surveys. Value in Health. ,vol. 14, pp. 1092- 1100 ,(2011) , 10.1016/J.JVAL.2011.06.002
Salomon Y. Cohen, Gerard Mimoun, Hassiba Oubraham, Alain Zourdani, Christian Malbrel, Stephane Queré, Véronique Schneider, Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 33, pp. 474- 481 ,(2013) , 10.1097/IAE.0B013E31827B6324
grupo estudio VIEW2 HHO Dominguez, None, Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. ,vol. 119, pp. 2537- 2548 ,(2012) , 10.1016/J.OPHTHA.2012.09.006